Venture Capital and Private Equity Principals · Hanau
As Corporate Venture Capital unit, we play a strategic role in Evonik’s goal to become a best-in-class specialty chemicals company. With a fund size of €400 million, Evonik Venture Capital has made >50 investments since 2012, both direct and fund investments. The investment scope ranges from early stage to growth stage with an investment volume of up to €15 million per portfolio company. Evonik Venture Capital has offices in Germany, the USA and China and invests in innovative technologies and disruptive business models in the fields of Nutrition & Care, Specialty Additives and Smart Materials, as well as enabling digital technologies and sustainability.